Validation of indirect calorimetry for measurement of energy expenditure in healthy volunteers undergoing pressure controlled non-invasive ventilation support

2011 ◽  
Vol 26 (1) ◽  
pp. 37-43 ◽  
Author(s):  
Waltteri Siirala ◽  
Tommi Noponen ◽  
Klaus T. Olkkola ◽  
Arno Vuori ◽  
Mari Koivisto ◽  
...  
2020 ◽  
Vol 15 (5) ◽  
pp. 767-771 ◽  
Author(s):  
Daniele Privitera ◽  
Laura Angaroni ◽  
Nicolò Capsoni ◽  
Elisa Forni ◽  
Federico Pierotti ◽  
...  

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Caroline Barry ◽  
Emma Larner ◽  
Helen Copsey ◽  
Matthew Smith ◽  
Guy Peryer

Author(s):  
Cristina Puricelli ◽  
Eleonora Volpato ◽  
Salvatore Sciurello ◽  
Antonello Nicolini ◽  
Paolo Banfi

he standard treatment for patients with neuromuscular respiratory failure is non-invasive ventilation (NIV) as non-invasive ventilation support-setting (NVS). NVS is administered through a nasal or face mask and/or mouthpiece with the potential to cause nasal ulcers, discomfort, and/or aesthetic issues, resulting in poor compliance. We reported the observation of a 45-year-old woman with limb-girdle muscular dystrophy (LGMD), secondary to Dysferlin deficiency, who was on NVS since 2017 for nocturnal hypoventilation. In 2018, despite nocturnal ventilation, due to weight gain and daytime hypoventilation, a nasal mask was introduced. We initiated daytime intermittent abdominal pressure ventilation (IAPV) to mitigate cosmetic problems, improving in pO2 and decreasing in pCO2 versus baseline (52>84 mmHg, 46>33 mmHg respectively) at 6 (85 mmHg, 42 mmHg) and 18 months (93 mmHg, 38 mmHg), respectively. IAPV was effective, safe, and well-tolerated in our patients who did not tolerate standard daytime NVS with the known interface.


2012 ◽  
Vol 27 (1) ◽  
pp. 101-102
Author(s):  
Waltteri Siirala ◽  
Tommi Noponen ◽  
Klaus T. Olkkola ◽  
Arno Vuori ◽  
Mari Koivisto ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document